Funding for the study was provided by the Chief Scientist Office, Scottish Government and Oncimmune Ltd.Peer reviewedPublisher PD
Background: The majority (around 80%) of cases of lung cancer are detected at a late stage when prog...
Funding: Scottish Government Health and Social Care Directorate, and Oncimmune Ltd.The EarlyCDT-Lung...
The EarlyCDT-Lung test is a high-specificity blood-based autoantibody biomarker that could contribut...
Background: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
Funding for the study was provided by the Chief Scientist Office, Scottish Government and Oncimmune ...
BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
Background: The majority (around 80%) of cases of lung cancer are detected at a late stage when prog...
Funding: Scottish Government Health and Social Care Directorate, and Oncimmune Ltd.The EarlyCDT-Lung...
The EarlyCDT-Lung test is a high-specificity blood-based autoantibody biomarker that could contribut...
Background: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
Funding for the study was provided by the Chief Scientist Office, Scottish Government and Oncimmune ...
BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of ...
Background: The majority (around 80%) of cases of lung cancer are detected at a late stage when prog...
Funding: Scottish Government Health and Social Care Directorate, and Oncimmune Ltd.The EarlyCDT-Lung...
The EarlyCDT-Lung test is a high-specificity blood-based autoantibody biomarker that could contribut...